Dr Betty Sallustio

• Postition: Principal Medical Scientist, Clinical Pharmacology, The Queen Elizabeth Hospital; Affiliate Senior Lecturer, Clinical and Experimental Pharmacology, The University of Adelaide.
• Qualifications: PhD
• Location: The Queen Elizabeth Hospital, telephone +61-8-8222 6510, fax +61-8-8222 6033, email benedetta.sallustio@nwahs.sa.gov.au
• Research: Dr Sallustio’s major interests cover the areas of therapeutic drug monitoring (TDM), drug metabolism and transporters, and mechanisms of drug-induced toxicity.
  Current areas of research include: the development of new analytical methods for the provision of TDM services, quality assurance, and the role of metabolism and transporters in interindividual susceptibility to drug toxicity and efficacy. Research studies are in progress examining methods to optimise dosing regimens for patients receiving the anti-anginal agent perhexiline; the role of pharmacogenomics in optimising clinical efficacy of immunosuppressant drugs; and the role of conjugative metabolism in the efficacy and toxicity of drugs.
• Teaching: Dr Sallustio supervises a number of research students enrolled in Honours, Masters and PhD studies and contributes to third year pharmacology undergraduate teaching.
• Other Academic Activities: Dr Sallustio is a member of a number of national and international professional scientific societies including, the Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists (ASCEPT), the International Society for the Study of Xenobiotics (ISSX) and the International Association for Therapeutic Drug Monitoring and Clinical Toxicology (IATDMCT). She currently serves as an executive committee member of the Drug Metabolism, Delivery and Pharmacokinetics Section of ASCEPT and the Pharmacokinetics Committee of IATDMCT. She also serves as a member of the CTN/CTX Subcommittee of The Queen Elizabeth Hospital Ethics of Human Research Committee, and manages an international quality assurance programme for pathology laboratories.